NT-proBNP reflects right ventricular structure and function in pulmonary hypertension

被引:72
作者
Gan, C. T.
McCann, G. P.
Marcus, J. T.
van Wolferen, S. A.
Twisk, J. W.
Boonstra, A.
Postmus, P. E.
Vonk-Noordegraf, A.
机构
[1] Vrije Univ Amsterdam, Dept Pulm Dis, Med Ctr, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Dept Phys & Med Technol, Med Ctr, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Dept Clin Epidemiol & Biostat, Inst Cardiovasc Res, NL-1007 MB Amsterdam, Netherlands
[4] Univ Hosp Leicester, NHS Trsut, Dept Cardiol, Leicester, Leics, England
关键词
magnetic resonance imaging; N-terminal pro brain natriuretic peptide; pulmonary hypertension; right ventricle;
D O I
10.1183/09031936.00016006
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The aim of the current study was to investigate whether alterations in N-terminal pro brain natriuretic peptide (NT-proBNP) reflect changes in right ventricular structure and function in pulmonary hypertension patients during treatment. The study consisted of 30 pulmonary hypertension patients; 15 newly diagnosed and 15 on long-term treatment. NT-proBNP, right heart catheterisation and cardiac magnetic resonance imaging measurements were performed, at baseline and follow-up. There were no significant differences between newly diagnosed patients and those on treatment at baseline or follow-up with respect to NT-proBNP, haemodynamics and right ventricular parameters. Relative changes in NT-proBNP during treatment were correlated to the relative changes in right ventricular end-diastolic volume index (r=0.59), right ventricular mass index (r=0.62) and right ventricular ejection fraction (r= -0.81). N-terminal pro brain natriuretic peptide measurements reflect changes in magnetic resonance imaging-measured right ventricular structure and function in pulmonary hypertension patients. An increase in N-terminal pro brain natriuretic peptide over time reflects right ventricular dilatation concomitant to hypertrophy and deterioration of systolic function.
引用
收藏
页码:1190 / 1194
页数:5
相关论文
共 23 条
[1]   Clinical applications of B-type natriuretic peptide (BNP) testing [J].
Cowie, MR ;
Jourdain, P ;
Maisel, A ;
Dahlstrom, U ;
Follath, F ;
Isnard, R ;
Luchner, A ;
McDonagh, T ;
Mair, J ;
Nieminen, M ;
Francis, G .
EUROPEAN HEART JOURNAL, 2003, 24 (19) :1710-1718
[2]   B-type natriuretic peptide in cardiovascular disease [J].
de Lemos, JA ;
McGuire, DK ;
Drazner, MH .
LANCET, 2003, 362 (9380) :316-322
[3]   Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension [J].
Fijalkowska, Anna ;
Kurzyna, Marcin ;
Torbicki, Adam ;
Szewczyk, Grzegorz ;
Florczyk, Michal ;
Pruszczyk, Piotr ;
Szturmowicz, Monika .
CHEST, 2006, 129 (05) :1313-1321
[4]   Guidelines on diagnosis and treatment of pulmonary arterial hypertension -: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology [J].
Galiè, N ;
Torbicki, A ;
Barst, R ;
Dartevelle, P ;
Haworth, S ;
Higenbottam, T ;
Olschewski, H ;
Peacock, A ;
Pietra, G ;
Rubin, LJ ;
Simonneau, G .
EUROPEAN HEART JOURNAL, 2004, 25 (24) :2243-2278
[5]   Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction [J].
Hammerer-Lercher, A ;
Neubauer, E ;
Müller, S ;
Pachinger, O ;
Puschendorf, B ;
Mair, J .
CLINICA CHIMICA ACTA, 2001, 310 (02) :193-197
[6]   Now predictors of outcome in idiopathic pulmonary arterial hypertension [J].
Kawut, SM ;
Horn, EM ;
Berekashvili, KK ;
Garofano, RP ;
Goldsmith, RL ;
Widlitz, AC ;
Rosenzweig, EB ;
Kerstein, D ;
Barst, RJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (02) :199-203
[7]   Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath [J].
Lainchbury, JG ;
Campbell, E ;
Frampton, CM ;
Yandle, TG ;
Nicholls, MG ;
Richards, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) :728-735
[8]   Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension [J].
Leuchte, HH ;
Holzapfel, M ;
Neurohr, C ;
Vogeser, M ;
Behr, J .
CHEST, 2005, 128 (04) :2368-2374
[9]   Clinical significance of brain natriuretic peptide in primary pulmonary hypertension [J].
Leuchte, HH ;
Holzapfel, M ;
Baumgartner, RA ;
Ding, I ;
Neurohr, C ;
Vogeser, M ;
Kolbe, T ;
Schwaiblmair, M ;
Behr, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) :764-770
[10]   Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction [J].
Maeda, K ;
Tsutamoto, T ;
Wada, A ;
Hisanaga, T ;
Kinoshita, M .
AMERICAN HEART JOURNAL, 1998, 135 (05) :825-832